Video transcripts
Surprising NMIBC lessons from CISTO
Read a transcript of Stephanie Chisolm and Janet Kukreja explaining how the findings of the CISTO trial may shape NMIBC care.
Expert perspective: Cretostimogene grenadenorepvec trials update
Read a transcript of Gary Steinberg summarizing the findings to date from the cretostimogene grenadenorepvec clinical trials program in NMIBC.
Expert perspective: CREST at ASCO 2025
Read a transcript of Thomas Powles discussing the rationale and latest findings from the CREST trial of sasanlimab plus BCG in NMIBC.
Transcript: EAU25: Expert reflection
Read a transcript of Ashish Kamat summarizing updates to our understanding of NMIBC from EAU25.
Transcript: EAU25: Expert reflection
Read a transcript of Ashish Kamat summarizing updates to our understanding of NMIBC from EAU25.
Transcript: Neal Shore on UGN-102 for NMIBC
Read the transcript of Neal Shore discussing how intravesical drug delivery systems could influence clinical decision-making for NMIBC.
Transcript: Neal Shore on ICIs and chemo in NMIBC
Read the transcript of Neal Shore discussing how therapeutic combinations including ICIs and chemotherapy might benefit patients with NMIBC.
Transcript: Neal Shore on BCG maintenance for NMIBC
Read the transcript of Neal Shore explaining the rationale for assessing nadofaragene firadenovec in patients with intermediate-risk NMIBC.
Transcript: Neal Shore on BCG maintenance for NMIBC
Read the transcript of Neal Shore discussing how to get the best from BCG maintenance therapy in the face of multiple challenges.
Developed by EPG Health. This content has been developed independently of the sponsor, Pfizer, which has had no editorial input into the content. EPG Health received funding from the sponsor to help provide healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. This content is intended for healthcare professionals only.